Skip to main content
logo
CASI Pharmaceuticals, Inc. (CASIF)
OTCMKTS · Delayed Price · Currency is USD
0.1288
-0.0312 (-19.50%)
At close: Sep 25, 2026

CASI Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
317449524112
Market Cap Growth
-89.77%-60.16%-54.03%291.63%-78.22%-69.41%
Enterprise Value
393242811776
Last Close Price
0.130.852.837.161.798.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-37.2937.29---
PS Ratio
0.130.841.542.820.563.71
PB Ratio
-0.05-0.4723.693.950.361.04
P/TBV Ratio
--27.184.270.561.55

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1.961.531.482.400.402.51

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.69-0.7411.960.880.020.02
Net Debt / Equity Ratio
-0.63-0.593.27-0.39-0.75-0.43
Net Debt / EBITDA Ratio
-0.98-0.52-0.160.442.081.39
Net Debt / FCF Ratio
--1.05-0.200.471.871.30
Asset Turnover
0.770.520.440.400.370.23
Inventory Turnover
3.083.111.651.263.947.70
Quick Ratio
0.110.200.862.453.784.43
Current Ratio
0.150.271.093.554.324.70
Return on Equity (ROE)
---301.80%-57.65%-46.04%-33.89%
Return on Assets (ROA)
-91.69%-67.52%-38.01%-18.43%-14.12%-16.55%
Return on Capital Employed (ROCE)
84.20%178.40%-227.70%-43.20%-33.40%-28.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1660.60%-275.15%-89.54%-28.24%-168.40%-32.77%
FCF Yield
-784.49%-118.92%-67.16%-21.15%-109.63%-32.00%
Buyback Yield / Dilution
-28.73%-20.85%-14.82%2.10%-0.27%-23.23%